Search - tctmd.com

Displaying 321 - 340 of 571

Sort: Relevancy | Date

Presentation TCT 2016

BIO-RESORT (TWENTE III): A Prospective, Randomized Three-Arm Trial Comparing Two Different Biodegradable Polymer-Based Drug-Eluting Stents and a Durable Polymer-Based Drug-Eluting Stent in an All-Comers Population of Patients With Coronary Artery Disease

Presenter: Gregg W. Stone, Wayne B. Batchelor, Clemens von Birgelen

October 30, 2016

Presentation ESC 2016

Drug-Eluting vs Bare Metal Stents in Saphenous Vein Grafts: The Prospective Randomized BASKET-SAVAGE Trial

Presenter: Raban V. Jeger

August 31, 2016

Presentation CCVVC 2016

Use of Drug Eluting Stents in the SFA: What are the Current Data, Real World Applications, Upcoming Trials

Presenter: Tyrone Collins

June 15, 2016

Presentation SOLACI 2016

Drug-eluting Stent and Dual Platelet Aggregation: What We Must Know

Presenter: Eduardo Nagib

June 09, 2016

Presentation EuroPCR 2016

Sealing Moderate Coronary Saphenous Vein Graft Lesions with Drug-Eluting Stents as a New Approach to Reducing Cardiac Events The VELETI II Randomized Trial

Presenter: Josep Rod?s-Cabau

May 19, 2016

Presentation Fellows 2016

Drug-Eluting Stents: Past, Present, and Future

Presenter: Gregg Stone

April 15, 2016

Presentation JIM 2016

Excimer laser facilitated coronary angioplasty of a heavy calcified lesion treated with drug eluting stents

Presenter: Antonio Mangieri

February 12, 2016

Presentation TCT 2015

A Randomized Comparison Among Drug Eluting Balloon, Drug Eluting Stents, and Conventional Balloon Angioplasty for Lesions in the Distal Internal Pudendal Artery in Patients with Erectile Dysfunction: The Perfect-3 Study

Presenter: Andrea Abizaid, Daniel Burkhoff, Tzung-Dau Wang

October 14, 2015

Presentation TCT 2015

TCT 66: Long-term Clinical Outcomes of Percutaneous Coronary Intervention Using Drug-Eluting Stent for Native Coronary Chronic Total Occlusion

Presenter: Sigmund Silber, Philip M. Urban, Pil Hyung Lee

October 13, 2015

Presentation TCT 2015

TCT 65: Two-Year Outcomes in Real-World Patients Treated With a Thin-Strut, Platinum-Chromium, Everolimus-Eluting Stent in the PROMUS Element Plus US Postapproval Study (PE-Plus PAS)

Presenter: Sigmund Silber, Philip M. Urban, David E. Kandzari

October 13, 2015

Presentation TCT 2015

TCT 64: Incidence, Predictors, and Impact of Postdischarge Bleeding Compared to Myocardial Infarction After Percutaneous Coronary Intervention

Presenter: Sigmund Silber, Philip M. Urban, Philippe Généreux

October 13, 2015

Presentation TCT 2015

TCT 80: Favorable Effect of Optimal Lipid-Lowering Therapy on Neointimal Tissue Characteristics After Drug-Eluting Stent Implantation Qualitative Optical Coherence Tomographic Analysis

Presenter: Lisa K. Jennings, Neal S. Kleiman, Ji-Yong Jang

October 13, 2015

Presentation TCT 2015

TCT 15: Multislice Computed Tomography Assessment of Absorb Bioresorbable Vascular Scaffold in Comparison With Metallic Drug-Eluting Stents Data From the ABSORB Japan Trial

Presenter: Stephen G. Ellis, Lorenz Raber, Kengo Tanabe

October 13, 2015

Presentation TCT 2015

TCT 63: One-Year Results of the REMEDEE Registry Clinical Outcomes After Deployment of the Abluminal Sirolimus-Coated Bioengineered Stent in a Multicenter, Prospective Postmarket Registry

Presenter: Sigmund Silber, Philip M. Urban, Robert de Winter

October 13, 2015

Presentation TCT 2015

TCT 47: Comparative Optical Coherent Tomographic Analysis of In-Stent Neoatherosclerosis Between First- and Second-Generation Drug-Eluting Stents

Presenter: Stephan Achenbach, Marc D. Feldman, Mineok Chang

October 13, 2015

Presentation TCT 2015

TCT 62: Predicting Value of Platelet Reactivity on Bleeding and Major Adverse Cardiac Events in Eastern Asian Percutaneous Coronary Intervention Patients

Presenter: Sigmund Silber, Philip M. Urban, Wenyao Wang

October 13, 2015

Presentation TCT 2015

TCT 19: Two-Year Clinical Outcomes and Chest Pain in 1,811 All-Comer Patients, Treated for Bifurcated Versus Nonbifurcated Lesions With Highly Deliverable Drug-Eluting Coronary Stents

Presenter: Eric A. Cohen, Truls Råmunddal, Liefke van der Heijden

October 13, 2015

Presentation TCT 2015

TCT 60: Long Coronary Lesions Treated With a Bioresorbable-Polymer Drug-Eluting Stent Experience From eNOBORI Registry

Presenter: Sigmund Silber, Philip M. Urban, Evgeny Kretov

October 13, 2015

Presentation TCT 2015

TCT 43: Mechanical Abnormalities Associated With Drug-Eluting Stent Thrombosis Analyzed by Optical Coherence Tomography in the National PESTO French Registry

Presenter: Stephan Achenbach, Marc D. Feldman, Nicolas Amabile

October 13, 2015

Presentation TCT 2015

TCT 59: The Impact of Timing of Ischemic and Hemorrhagic Events on Mortality After DES The ADAPT-DES study

Presenter: Sigmund Silber, Philip M. Urban, Sorin J. Brener

October 13, 2015

Advertisement

BIO-RESORT (TWENTE III): A Prospective, Randomized Three-Arm Trial Comparing Two Different Biodegradable Polymer-Based Drug-Eluting Stents and a Durable Polymer-Based Drug-Eluting Stent in an All-Comers Population of Patients With Coronary Artery Disease

Drug-Eluting vs Bare Metal Stents in Saphenous Vein Grafts: The Prospective Randomized BASKET-SAVAGE Trial

Use of Drug Eluting Stents in the SFA: What are the Current Data, Real World Applications, Upcoming Trials

Drug-eluting Stent and Dual Platelet Aggregation: What We Must Know

Sealing Moderate Coronary Saphenous Vein Graft Lesions with Drug-Eluting Stents as a New Approach to Reducing Cardiac Events The VELETI II Randomized Trial

Drug-Eluting Stents: Past, Present, and Future

Excimer laser facilitated coronary angioplasty of a heavy calcified lesion treated with drug eluting stents

A Randomized Comparison Among Drug Eluting Balloon, Drug Eluting Stents, and Conventional Balloon Angioplasty for Lesions in the Distal Internal Pudendal Artery in Patients with Erectile Dysfunction: The Perfect-3 Study

TCT 66: Long-term Clinical Outcomes of Percutaneous Coronary Intervention Using Drug-Eluting Stent for Native Coronary Chronic Total Occlusion

TCT 65: Two-Year Outcomes in Real-World Patients Treated With a Thin-Strut, Platinum-Chromium, Everolimus-Eluting Stent in the PROMUS Element Plus US Postapproval Study (PE-Plus PAS)

TCT 64: Incidence, Predictors, and Impact of Postdischarge Bleeding Compared to Myocardial Infarction After Percutaneous Coronary Intervention

TCT 80: Favorable Effect of Optimal Lipid-Lowering Therapy on Neointimal Tissue Characteristics After Drug-Eluting Stent Implantation Qualitative Optical Coherence Tomographic Analysis

TCT 15: Multislice Computed Tomography Assessment of Absorb Bioresorbable Vascular Scaffold in Comparison With Metallic Drug-Eluting Stents Data From the ABSORB Japan Trial

TCT 63: One-Year Results of the REMEDEE Registry Clinical Outcomes After Deployment of the Abluminal Sirolimus-Coated Bioengineered Stent in a Multicenter, Prospective Postmarket Registry

TCT 47: Comparative Optical Coherent Tomographic Analysis of In-Stent Neoatherosclerosis Between First- and Second-Generation Drug-Eluting Stents

TCT 62: Predicting Value of Platelet Reactivity on Bleeding and Major Adverse Cardiac Events in Eastern Asian Percutaneous Coronary Intervention Patients

TCT 19: Two-Year Clinical Outcomes and Chest Pain in 1,811 All-Comer Patients, Treated for Bifurcated Versus Nonbifurcated Lesions With Highly Deliverable Drug-Eluting Coronary Stents

TCT 60: Long Coronary Lesions Treated With a Bioresorbable-Polymer Drug-Eluting Stent Experience From eNOBORI Registry

TCT 43: Mechanical Abnormalities Associated With Drug-Eluting Stent Thrombosis Analyzed by Optical Coherence Tomography in the National PESTO French Registry

TCT 59: The Impact of Timing of Ischemic and Hemorrhagic Events on Mortality After DES The ADAPT-DES study

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content